GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (BSP:I1DX34) » Definitions » Retained Earnings

IDEXX Laboratories (BSP:I1DX34) Retained Earnings : R$23,306 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is IDEXX Laboratories Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. IDEXX Laboratories's retained earnings for the quarter that ended in Mar. 2024 was R$23,306 Mil.

IDEXX Laboratories's quarterly retained earnings increased from Sep. 2023 (R$20,990 Mil) to Dec. 2023 (R$21,778 Mil) and increased from Dec. 2023 (R$21,778 Mil) to Mar. 2024 (R$23,306 Mil).

IDEXX Laboratories's annual retained earnings increased from Dec. 2021 (R$16,515 Mil) to Dec. 2022 (R$18,881 Mil) and increased from Dec. 2022 (R$18,881 Mil) to Dec. 2023 (R$21,778 Mil).


IDEXX Laboratories Retained Earnings Historical Data

The historical data trend for IDEXX Laboratories's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Retained Earnings Chart

IDEXX Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,549.34 11,192.78 16,514.80 18,880.97 21,777.51

IDEXX Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19,863.43 19,598.36 20,989.72 21,777.51 23,306.21

IDEXX Laboratories Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


IDEXX Laboratories  (BSP:I1DX34) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


IDEXX Laboratories (BSP:I1DX34) Business Description

Traded in Other Exchanges
Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.

IDEXX Laboratories (BSP:I1DX34) Headlines

No Headlines